96804 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses; Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus; Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV; HIV-1 ; HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p7, p6, p66/68, p51/52, p31/34, p32, p40
Compositions and Methods for Targeted Delivery of CRISPR-CAS Effector Polypeptides and Transgenes
#2STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS
#3DELIVERY OF HETEROLOGOUS PROTEINS
#4SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF NUCLEIC ACID PROGRAMMABLE FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
#5METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#6METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#7METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE USING CONSERVED ELEMENT CONSTRUCTS
#8ARC-BASED CAPSIDS AND USES THEREOF
#9Methods and reagents for assessing the presence or absence of replication competent virus
#10COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF CRISPR-CAS EFFECTOR POLYPEPTIDES AND TRANSGENES
#11Expression systems comprising nucleic acids encoding HIV-1 protease cleavage site polypeptides
#12Multivalent HIV vaccine boost compositions and methods of use
#13HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens
#14Human cytomegalovirus comprising exogenous antigens
#15MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION
#16Virus-like particles and use thereof
#17Usages of recombinant extracellular vesicles
#18Methods and reagents for assessing the presence or absence of replication competent virus
#19Methods and constructs for production of lentiviral vector
#20Methods of inducing an immune response against HIV-1 utilizing nucleic acids encoding polypeptides containing HIV-1 protease cleavage sites
#21Human cytomegalovirus comprising exogenous antigens
#22Stable cell lines for retroviral production
#23T CELL RECEPTORS FROM THE HIV-SPECIFIC REPERTOIRE, MEANS FOR THEIR PRODUCTION AND THERAPEUTIC USES THEREOF
#24Viral particle for the transfer of RNAs, especially into cells involved in immune response
#25Nanoparticles carrying immunogenic peptides targeting HIV-1 protease cleavage sites
#26Nucleic acids encoding mosaic conserved region HIV immunogenic polypeptides
#27Recombinant HCMV and RHCMV vectors and uses thereof
#28Human cytomegalovirus comprising exogenous antigens
#29Methods of inducing an immune response against HIV by administering immunogenic peptides obtained from protease cleavage sites
#30Recombinant HCMV and RHCMV vectors and uses thereof
#31Immunogenic compositions comprising FIV and HIV gag antigens
#32Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism
#33Method for the detection of HIV-1 antibodies utilizing a peptide containing a novel gp41 epitope
#34Recombinant HCMV and RHCMV vectors and uses thereof
#35Monoclonal antibodies to human immunodeficiency virus and uses thereof
#36MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION
#37MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS AND USES THEREOF
#38Methods for the detection of HIV-1-specific antibodies employing GP41 polypeptides
#39COMPOSITIONS AND METHODS FOR THE DETECTION OF HIV-1/HIV-2 INFECTION
#40Vector for expressing NC protein of HIV and method for producing NC protein using the same
#41Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens
#42Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein
#43Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism
#44Mutated HIV Nef for modulating immunity
#45Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#46Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#47Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#48Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26).
#49Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
#50Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)